KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Chemed (CHE) Interest & Investment Income (2016 - 2026)

Chemed filings provide 17 years of Interest & Investment Income readings, the most recent being $890000.0 for Q1 2026.

  • For the quarter ending Q1 2026, Interest & Investment Income fell 57.13% year-over-year to $890000.0, compared with a TTM value of $7.6 million through Mar 2026, down 39.26%, and an annual FY2025 reading of $8.7 million, down 40.14% over the prior year.
  • Interest & Investment Income hit $890000.0 in Q1 2026 for Chemed, down from $1.6 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $4.2 million in Q1 2024, with the low at $62000.0 in Q3 2022.
  • Median Interest & Investment Income over the past 5 years was $2.1 million (2025), compared with a mean of $1.8 million.
  • The sharpest move saw Interest & Investment Income soared 4985.07% in 2023, then plummeted 57.13% in 2026.
  • Year by year, Interest & Investment Income stood at $67000.0 in 2022, then surged by 4985.07% to $3.4 million in 2023, then dropped by 5.93% to $3.2 million in 2024, then tumbled by 51.36% to $1.6 million in 2025, then crashed by 42.91% to $890000.0 in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $890000.0, $1.6 million, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.